Skip to main content
. 2020 Feb 27;29(5):514–522. doi: 10.1177/0961203320908932

Figure 3.

Figure 3

Types of treatment of subjects with SLE at both last evaluation and ever received in the ‘Attikon’ cohort. GCs: glucocorticoids; IV-MP: intravenous methylprednisolone; HCQ: hydroxychloroquine; IV-CYC: intravenous cyclophosphamide; MMF: mycophenolate; AZA: azathioprine; CsA: cyclosporine; MTX: methotrexate.